1. Home
  2. ICFI vs MPLT Comparison

ICFI vs MPLT Comparison

Compare ICFI & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$76.74

Market Cap

1.3B

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

BUY

Current Price

$38.39

Market Cap

1.3B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ICFI
MPLT
Founded
1969
2018
Country
United States
United States
Employees
N/A
133
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
ICFI
MPLT
Price
$76.74
$38.39
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$99.25
$32.67
AVG Volume (30 Days)
283.4K
477.1K
Earning Date
05-07-2026
05-28-2026
Dividend Yield
0.82%
N/A
EPS Growth
N/A
N/A
EPS
1.12
N/A
Revenue
$1,229,162,000.00
N/A
Revenue This Year
$4.12
N/A
Revenue Next Year
$5.33
N/A
P/E Ratio
$68.16
N/A
Revenue Growth
3.72
N/A
52 Week Low
$58.83
$12.24
52 Week High
$101.71
$39.91

Technical Indicators

Market Signals
Indicator
ICFI
MPLT
Relative Strength Index (RSI) 61.86 65.36
Support Level $73.89 $26.20
Resistance Level $83.85 N/A
Average True Range (ATR) 3.22 2.80
MACD 0.68 0.66
Stochastic Oscillator 79.94 83.61

Price Performance

Historical Comparison
ICFI
MPLT

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: